Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

647 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antidiabetic Therapy in the Treatment of Nonalcoholic Steatohepatitis.
Sumida Y, Yoneda M, Tokushige K, Kawanaka M, Fujii H, Yoneda M, Imajo K, Takahashi H, Eguchi Y, Ono M, Nozaki Y, Hyogo H, Koseki M, Yoshida Y, Kawaguchi T, Kamada Y, Okanoue T, Nakajima A, Jsg-Nafld JSGON. Sumida Y, et al. Among authors: nozaki y. Int J Mol Sci. 2020 Mar 11;21(6):1907. doi: 10.3390/ijms21061907. Int J Mol Sci. 2020. PMID: 32168769 Free PMC article. Review.
Life style-related diseases of the digestive system: gene expression in nonalcoholic steatohepatitis patients and treatment strategies.
Yoneda M, Endo H, Nozaki Y, Tomimoto A, Fujisawa T, Fujita K, Yoneda K, Takahashi H, Saito S, Iwasaki T, Yamamoto S, Tsutsumi S, Aburatani H, Wada K, Hotta K, Nakajima A. Yoneda M, et al. Among authors: nozaki y. J Pharmacol Sci. 2007 Oct;105(2):151-6. doi: 10.1254/jphs.fm0070063. Epub 2007 Oct 6. J Pharmacol Sci. 2007. PMID: 17928738 Free article. Review.
Novel findings for the development of drug therapy for various liver diseases: Liver microsomal triglyceride transfer protein activator may be a possible therapeutic agent in non-alcoholic steatohepatitis.
Fujita K, Imajo K, Shinohara Y, Nozaki Y, Wada K, Yoneda M, Endo H, Takahashi H, Abe Y, Inamori M, Shimamura T, Kobayashi N, Kirikoshi H, Kubota K, Saito S, Nakajima A. Fujita K, et al. Among authors: nozaki y. J Pharmacol Sci. 2011;115(3):270-3. doi: 10.1254/jphs.10r14fm. Epub 2011 Feb 22. J Pharmacol Sci. 2011. PMID: 21350309 Free article. Review.
LDL-migration index (LDL-MI), an indicator of small dense low-density lipoprotein (sdLDL), is higher in non-alcoholic steatohepatitis than in non-alcoholic fatty liver: a multicenter cross-sectional study.
Imajo K, Hyogo H, Yoneda M, Honda Y, Kessoku T, Tomeno W, Ogawa Y, Taguri M, Mawatari H, Nozaki Y, Fujita K, Kirikoshi H, Saito S, Sumida Y, Ono M, Wada K, Nakajima A, Eguchi Y. Imajo K, et al. Among authors: nozaki y. PLoS One. 2014 Dec 26;9(12):e115403. doi: 10.1371/journal.pone.0115403. eCollection 2014. PLoS One. 2014. PMID: 25541989 Free PMC article. Clinical Trial.
Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease and alcoholic liver disease: multicenter survey.
Tokushige K, Hyogo H, Nakajima T, Ono M, Kawaguchi T, Honda K, Eguchi Y, Nozaki Y, Kawanaka M, Tanaka S, Imajo K, Sumida Y, Kamada Y, Fujii H, Suzuki Y, Kogiso T, Karino Y, Munekage K, Kuromatsu R, Oeda S, Yanase M, Mori K, Ogawa Y, Seko Y, Takehara T, Itoh Y, Nakajima A, Kanemasa K, Nishino K, Masaki N, Takahashi H, Seike M, Torimura T, Saibara T, Toyota J, Chayama K, Hashimoto E. Tokushige K, et al. Among authors: nozaki y. J Gastroenterol. 2016 Jun;51(6):586-96. doi: 10.1007/s00535-015-1129-1. Epub 2015 Oct 11. J Gastroenterol. 2016. PMID: 26456168
A Data Mining-based Prognostic Algorithm for NAFLD-related Hepatoma Patients: A Nationwide Study by the Japan Study Group of NAFLD.
Kawaguchi T, Tokushige K, Hyogo H, Aikata H, Nakajima T, Ono M, Kawanaka M, Sawada K, Imajo K, Honda K, Takahashi H, Mori K, Tanaka S, Seko Y, Nozaki Y, Kamada Y, Fujii H, Kawaguchi A, Takehara T, Yanase M, Sumida Y, Eguchi Y, Seike M, Yoneda M, Suzuki Y, Saibara T, Karino Y, Chayama K, Hashimoto E, George J, Torimura T. Kawaguchi T, et al. Among authors: nozaki y. Sci Rep. 2018 Jul 11;8(1):10434. doi: 10.1038/s41598-018-28650-0. Sci Rep. 2018. PMID: 29992975 Free PMC article.
Clinical features of hepatocellular carcinoma in nonalcoholic fatty liver disease patients without advanced fibrosis.
Kodama K, Kawaguchi T, Hyogo H, Nakajima T, Ono M, Seike M, Takahashi H, Nozaki Y, Kawanaka M, Tanaka S, Imajo K, Sumida Y, Kamada Y, Fujii H, Seko Y, Takehara T, Itoh Y, Nakajima A, Masaki N, Torimura T, Saibara T, Karino Y, Chayama K, Tokushige K. Kodama K, et al. Among authors: nozaki y. J Gastroenterol Hepatol. 2019 Sep;34(9):1626-1632. doi: 10.1111/jgh.14608. Epub 2019 Mar 6. J Gastroenterol Hepatol. 2019. PMID: 30668889
Nitric oxide plays a crucial role in the development/progression of nonalcoholic steatohepatitis in the choline-deficient, l-amino acid-defined diet-fed rat model.
Fujita K, Nozaki Y, Yoneda M, Wada K, Takahashi H, Kirikoshi H, Inamori M, Saito S, Iwasaki T, Terauchi Y, Maeyama S, Nakajima A. Fujita K, et al. Among authors: nozaki y. Alcohol Clin Exp Res. 2010 Feb;34 Suppl 1:S18-24. doi: 10.1111/j.1530-0277.2008.00756.x. Epub 2009 Nov 5. Alcohol Clin Exp Res. 2010. PMID: 18986378
Serum ferritin is a clinical biomarker in Japanese patients with nonalcoholic steatohepatitis (NASH) independent of HFE gene mutation.
Yoneda M, Nozaki Y, Endo H, Mawatari H, Iida H, Fujita K, Yoneda K, Takahashi H, Kirikoshi H, Inamori M, Kobayashi N, Kubota K, Saito S, Maeyama S, Hotta K, Nakajima A. Yoneda M, et al. Among authors: nozaki y. Dig Dis Sci. 2010 Mar;55(3):808-14. doi: 10.1007/s10620-009-0771-y. Epub 2009 Mar 7. Dig Dis Sci. 2010. PMID: 19267193
647 results